These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 17637110

  • 1. Molecular targets for disrupting leukocyte trafficking during multiple sclerosis.
    McCandless EE, Klein RS.
    Expert Rev Mol Med; 2007 Jul 19; 9(20):1-19. PubMed ID: 17637110
    [Abstract] [Full Text] [Related]

  • 2. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
    Correale J, Villa A.
    Autoimmunity; 2007 Mar 19; 40(2):148-60. PubMed ID: 17453713
    [Abstract] [Full Text] [Related]

  • 3. Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patients.
    Kim HJ, Biernacki K, Prat A, Antel JP, Bar-Or A.
    Clin Immunol; 2004 Apr 19; 111(1):38-46. PubMed ID: 15093550
    [Abstract] [Full Text] [Related]

  • 4. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma.
    Archambault AS, Sim J, Gimenez MA, Russell JH.
    Eur J Immunol; 2005 Apr 19; 35(4):1076-85. PubMed ID: 15761850
    [Abstract] [Full Text] [Related]

  • 5. Is damage in central nervous system due to inflammation?
    Chavarria A, Alcocer-Varela J.
    Autoimmun Rev; 2004 Jun 19; 3(4):251-60. PubMed ID: 15246020
    [Abstract] [Full Text] [Related]

  • 6. Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation.
    Ubogu EE, Callahan MK, Tucky BH, Ransohoff RM.
    J Neuroimmunol; 2006 Oct 19; 179(1-2):132-44. PubMed ID: 16857269
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic targeting of chemokine signaling in Multiple Sclerosis.
    Hamann I, Zipp F, Infante-Duarte C.
    J Neurol Sci; 2008 Nov 15; 274(1-2):31-8. PubMed ID: 18706659
    [Abstract] [Full Text] [Related]

  • 8. Perivascular spaces and the two steps to neuroinflammation.
    Owens T, Bechmann I, Engelhardt B.
    J Neuropathol Exp Neurol; 2008 Dec 15; 67(12):1113-21. PubMed ID: 19018243
    [Abstract] [Full Text] [Related]

  • 9. The expression and function of chemokines involved in CNS inflammation.
    Ubogu EE, Cossoy MB, Ransohoff RM.
    Trends Pharmacol Sci; 2006 Jan 15; 27(1):48-55. PubMed ID: 16310865
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
    Larochelle C, Alvarez JI, Prat A.
    FEBS Lett; 2011 Dec 01; 585(23):3770-80. PubMed ID: 21550344
    [Abstract] [Full Text] [Related]

  • 13. [Multiple sclerosis: epidemiology, molecular pathology and therapy].
    Steck AJ, Schaeren-Wiemers N.
    Schweiz Med Wochenschr; 1999 Nov 20; 129(46):1764-8. PubMed ID: 10603650
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain.
    Greenwood J, Heasman SJ, Alvarez JI, Prat A, Lyck R, Engelhardt B.
    Neuropathol Appl Neurobiol; 2011 Feb 20; 37(1):24-39. PubMed ID: 20946472
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases.
    Pedemonte E, Mancardi G, Giunti D, Corcione A, Benvenuto F, Pistoia V, Uccelli A.
    Pharmacol Ther; 2006 Sep 20; 111(3):555-66. PubMed ID: 16442633
    [Abstract] [Full Text] [Related]

  • 18. Targeting leukocyte recruitment in the treatment of psoriasis.
    Li YY, Zollner TM, Schön MP.
    Clin Dermatol; 2008 Sep 20; 26(5):527-38. PubMed ID: 18755372
    [Abstract] [Full Text] [Related]

  • 19. Migratory pathways of gammadelta T cells and response to CXCR3 and CXCR4 ligands: adhesion molecules involved and implications for multiple sclerosis pathogenesis.
    Poggi A, Zancolli M, Catellani S, Borsellino G, Battistini L, Zocchi MR.
    Ann N Y Acad Sci; 2007 Jun 20; 1107():68-78. PubMed ID: 17804534
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.